{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:49:36Z","timestamp":1793152176045,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ahj.2026.107516","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:45:51Z","timestamp":1782143151000},"page":"107516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Considerations for using atrial fibrillation burden as a surrogate endpoint: A report from the Cardiovascular Sciences Research Consortium"],"prefix":"10.1016","volume":"301","author":[{"given":"Krishna","family":"Pundi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charu","family":"Gandotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fortunato","family":"Senatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8493-5123","authenticated-orcid":false,"given":"Jason G.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4857-9125","authenticated-orcid":false,"given":"Charles Michael","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Lubitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Piccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3129-6161","authenticated-orcid":false,"given":"Andrea","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8025-0904","authenticated-orcid":false,"given":"Mintu P.","family":"Turakhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4772-7624","authenticated-orcid":false,"given":"Jonathan","family":"Seltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2026.107516_bib0001","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107516_bib0002","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107516_bib0003","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/jama.2024.17921","article-title":"Pulmonary vein isolation vs Sham intervention in symptomatic atrial fibrillation: the SHAM-PVI randomized clinical trial","volume":"332","author":"Dulai","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2026.107516_bib0004","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107516_bib0005","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa0803778","article-title":"Effect of Dronedarone on cardiovascular events in atrial fibrillation","volume":"360","author":"Hohnloser","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107516_bib0006","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJMoa041705","article-title":"Amiodarone versus Sotalol for atrial fibrillation","volume":"352","author":"Singh","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107516_bib0007","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1602014","article-title":"Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation","volume":"374","author":"Kuck","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107516_bib0008","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacc.2024.05.001","article-title":"Pulsed field vs conventional thermal ablation for paroxysmal atrial fibrillation: recurrent atrial arrhythmia burden","volume":"84","author":"Reddy","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107516_bib0009","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1161\/CIRCULATIONAHA.123.063988","article-title":"Pulsed field ablation for the treatment of atrial fibrillation: PULSED AF pivotal trial","volume":"147","author":"Verma","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107516_bib0010","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa054686","article-title":"Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter","volume":"357","author":"Singh","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107516_bib0011","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.006274","article-title":"Thirty-second gold standard definition of atrial fibrillation and its relationship with subsequent arrhythmia patterns: analysis of a large prospective device database","volume":"11","author":"Steinberg","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ahj.2026.107516_bib0012","unstructured":"U.S. Food and Drug Administration. Surrogate endpoint resources for drug and biologic development [Internet]; 2018. https:\/\/www.fda.gov\/drugs\/development-resources\/surrogate-endpoint-resources-drug-and-biologic-development#_ftn1 [accessed 12 February 2026]."},{"key":"10.1016\/j.ahj.2026.107516_bib0013","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41591-018-0268-3","article-title":"Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network","volume":"25","author":"Hannun","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.ahj.2026.107516_bib0014","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.hrthm.2016.03.005","article-title":"Performance of a new atrial fibrillation detection algorithm in a miniaturized insertable cardiac monitor: results from the Reveal LINQ Usability study","volume":"13","author":"Sanders","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ahj.2026.107516_bib0015","doi-asserted-by":"crossref","DOI":"10.1111\/anec.12960","article-title":"Accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation: results of the BioVAD study","volume":"27","author":"Assaf","year":"2022","journal-title":"Noninvasive Electrocardiol"},{"key":"10.1016\/j.ahj.2026.107516_bib0016","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf280","article-title":"Wearable smartwatches for atrial fibrillation detection and burden estimation after ablation: comparison with continuous monitoring","author":"Aguilar","year":"2025","journal-title":"Europace"},{"issue":"21","key":"10.1016\/j.ahj.2026.107516_bib0017","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/heartjnl-2024-324848","article-title":"Anticoagulation in patients with low-burden atrial fibrillation: new evidence focussing on device-detected AF","volume":"111","author":"Becher","year":"2025","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2026.107516_bib0018","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1093\/eurheartj\/ehae373","article-title":"Atrial fibrillation burden: a new outcome predictor and therapeutic target","volume":"45","author":"Becher","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107516_bib0019","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with Edoxaban in patients with atrial high-rate episodes","volume":"389","author":"Kirchhof","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107516_bib0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for stroke prevention in subclinical atrial fibrillation","volume":"390","author":"Healey","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107516_bib0021","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIRCULATIONAHA.124.069903","article-title":"Risk of stroke or systemic embolism according to baseline frequency and duration of subclinical atrial fibrillation: insights from the ARTESiA trial","volume":"150","author":"McIntyre","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107516_bib0022","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa2408308","article-title":"Left atrial appendage closure after ablation for atrial fibrillation","volume":"392","author":"Wazni","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107516_bib0023","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2025.14679","article-title":"Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation: the ALONE-AF randomized clinical trial","author":"Kim","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2026.107516_bib0024","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/CIRCULATIONAHA.124.071176","article-title":"Randomized invitation to systematic NT-proBNP and ECG screening in 75-year-olds to detect atrial fibrillation: STROKESTOP II","volume":"150","author":"Kemp Gudmundsdottir","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107516_bib0025","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(21)01637-8","article-title":"Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial","volume":"398","author":"Svennberg","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2026.107516_bib0026","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0140-6736(21)01698-6","article-title":"Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial","volume":"398","author":"Svendsen","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2026.107516_bib0027","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1038\/s41598-022-05688-9","article-title":"Long-term risk of adverse outcomes according to atrial fibrillation type","volume":"12","author":"Blum","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ahj.2026.107516_bib0028","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/eurheartj\/ehw007","article-title":"The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis","volume":"37","author":"Ganesan","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107516_bib0029","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/2396987319896674","article-title":"The impact of atrial fibrillation type on the risks of thromboembolic recurrence, mortality and major haemorrhage in patients with previous stroke: a systematic review and meta-analysis of observational studies","volume":"5","author":"Mentel","year":"2020","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.ahj.2026.107516_bib0030","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.121.010304","article-title":"Arrhythmic burden and the risk of cardiovascular outcomes in patients with paroxysmal atrial fibrillation and cardiac implanted electronic devices","volume":"15","author":"Chew","year":"2022","journal-title":"Circ Arrhyth Electrophysiol"},{"key":"10.1016\/j.ahj.2026.107516_bib0031","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ahj.2006.08.011","article-title":"Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry Assessing Costs, Therapies, adverse events and lifestyle (FRACTAL) study","volume":"152","author":"Reynolds","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2026.107516_bib0032","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.25473","article-title":"Association between quality of life and procedural outcome after catheter ablation for atrial fibrillation: a secondary analysis of a randomized clinical trial","volume":"3","author":"Terricabras","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ahj.2026.107516_bib0033","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1001\/jamacardio.2021.3063","article-title":"Association of atrial fibrillation burden with health-related quality of life after atrial fibrillation ablation: substudy of the cryoballoon vs contact-force atrial fibrillation ablation (CIRCA-DOSE) randomized clinical trial","volume":"6","author":"Samuel","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ahj.2026.107516_bib0034","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/eurheartj\/ehac692","article-title":"Healthcare utilization and quality of life for atrial fibrillation burden: the CIRCA-DOSE study","volume":"44","author":"Andrade","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107516_bib0035","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/CIRCULATIONAHA.124.071517","article-title":"Catheter ablation in patients with end-stage heart failure and atrial fibrillation: two-year follow-up of the CASTLE-HTx trial","volume":"150","author":"Sohns","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107516_bib0036","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.125.074485","article-title":"Pulsed field ablation of persistent atrial fibrillation with continuous electrocardiographic monitoring follow-up: ADVANTAGE AF phase 2","volume":"152","author":"Reddy","year":"2025","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ahj.2026.107516_bib0037","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa2509688","article-title":"Antithrombotic therapy after successful catheter ablation for atrial fibrillation","volume":"394","author":"Verma","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107516_bib0038","unstructured":"U.S. Food and Drug Administration. Clinical study designs for surgical ablation devices for treatment of atrial fibrillation [Internet]; 2013. https:\/\/www.fda.gov\/media\/77365\/download [accessed 17 February 2026]."},{"key":"10.1016\/j.ahj.2026.107516_bib0039","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1093\/eurheartj\/ehae373","article-title":"Atrial fibrillation burden: a new outcome predictor and therapeutic target","volume":"45","author":"Becher","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107516_bib0040","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf019","article-title":"Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association","volume":"27","author":"Doehner","year":"2025","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2026.107516_bib0041","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1056\/NEJMra2301903","article-title":"Wearable digital health technologies for monitoring in cardiovascular medicine","volume":"390","author":"Spatz","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107516_bib0042","unstructured":"U.S. Food and Drug Administration. Medical device development tool summary of evidence and basis of qualification - apple atrial fibrillation history feature [Internet]. https:\/\/www.fda.gov\/media\/178230\/download?attachment"},{"key":"10.1016\/j.ahj.2026.107516_bib0043","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.121.056109","article-title":"Influence of monitoring strategy on assessment of ablation success and postablation atrial fibrillation burden assessment: implications for practice and clinical trial design","volume":"145","author":"Aguilar","year":"2022","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ahj.2026.107516_bib0044","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/eurheartj\/ehaf647","article-title":"Atrial fibrillation burden is underestimated by non-invasive monitoring: the CIRCA-DOSE trial","volume":"47","author":"Aguilar","year":"2026","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107516_bib0045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10840-019-00515-0","article-title":"A randomized trial evaluating the accuracy of AF detection by four external ambulatory ECG monitors compared to permanent pacemaker AF detection","volume":"57","author":"Eysenck","year":"2020","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.ahj.2026.107516_bib0046","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.hrthm.2023.04.011","article-title":"Simultaneous comparison of patch versus multielectrode cardiac monitoring for the detection of arrhythmias: the COMPARE study","volume":"20","author":"Garg","year":"2023","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ahj.2026.107516_bib0047","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa2408308","article-title":"Left atrial appendage closure after ablation for atrial fibrillation","volume":"392","author":"Wazni","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107516_bib0048","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107516_bib0049","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/jamacardio.2018.1176","article-title":"Association of burden of atrial fibrillation with risk of ischemic stroke in adults with paroxysmal atrial fibrillation: the KP-RHYTHM study","volume":"3","author":"Go","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ahj.2026.107516_bib0050","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","article-title":"The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study","volume":"2","author":"Glotzer","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ahj.2026.107516_bib0051","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1093\/eurheartj\/ehac471","article-title":"Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial","volume":"43","author":"Eckardt","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107516_bib0052","unstructured":"U.S. Food and Drug Administration. Medical device development tools [Internet]; 2025. https:\/\/www.fda.gov\/medical-devices\/medical-device-development-tools-mddt [accessed 1 March 2026]."},{"key":"10.1016\/j.ahj.2026.107516_bib0053","unstructured":"U.S. Food and Drug Administration. Drug development tools [Internet]; 2025. https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/drug-development-tools-ddts [accessed 1 March 2026]."}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287032600178X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287032600178X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:24:25Z","timestamp":1787257465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000287032600178X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":53,"alternative-id":["S000287032600178X"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107516","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Considerations for using atrial fibrillation burden as a surrogate endpoint: A report from the Cardiovascular Sciences Research Consortium","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107516","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107516"}}